Methods and compositions for cancer treatment
US-2024424094-A1 · Dec 26, 2024 · US
Compositions and methods for therapy and diagnosis of cancer and cancer metastasis
US9061007B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9061007-B2 |
| Application number | US-201313826030-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 14, 2013 |
| Priority date | Oct 12, 2006 |
| Publication date | Jun 23, 2015 |
| Grant date | Jun 23, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to methods which make possible to assess and/or prognose a cancer disease, the metastatic behavior of a cancer disease and/or the occurrence of a relapse of cancer. In particular, the methods of the invention make possible to assess and/or prognose the occurrence of cancer metastasis, in particular distant metastasis. Preferably, the methods of the invention allow to discriminate malign from benign conditions.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of treating a cancer, metastasis of a cancer or relapse of a cancer comprising administering an effective amount of a pharmaceutical composition comprising: (i) an agent which is effective in reducing or inhibiting expression or activity of TPTE and/or which binds to TPTE and has tumor destroying or tumor inhibiting activity when administered to a patient, and (ii) an agent which is effective in reducing or inhibiting expression or activity…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Physics · mapped topic
Physics · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9061007B2 cover?
- The present invention relates to methods which make possible to assess and/or prognose a cancer disease, the metastatic behavior of a cancer disease and/or the occurrence of a relapse of cancer. In particular, the methods of the invention make possible to assess and/or prognose the occurrence of cancer metastasis, in particular distant metastasis. Preferably, the methods of the invention allow …
- Who is the assignee on this patent?
- Biontech Ag, Johannes Gutenberg Universität Mainz, Univ Mainz Johannes Gutenberg
- What technology area does this patent fall under?
- Primary CPC classification A61K39/39558. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).